Hepatitis C News and Research

Latest Hepatitis C News and Research

Inhalation therapeutics against COVID-19

A recent study published in the Pulmonary Pharmacology & Therapeutics journal described different inhalation therapeutic agents for treating respiratory viral infections like coronavirus disease 2019 (COVID-19).

17 Oct 2022

RNA-dependent RNA polymerase inhibitors in COVID-19 therapy

A new paper reviews current knowledge of RdRp inhibitors that could be developed further to provide broadly effective antivirals against SARS-CoV-2 in particular and CoVs in general.

10 Oct 2022

The involvement of minor intron-containing gene-encoded proteins in viral infections

Researchers explored the role of the minor intron-containing gene (MIG)-encoded proteins (MIG-Ps) depending on minor spliceosome-MiG excision to be expressed in infections by pathogenic viruses.

6 Oct 2022

Global burden of liver cancer could rise by more than 55% by 2040, analysis reveals

A new analysis reveals that primary liver cancer was among the top three causes of cancer death in 46 countries in 2020 and the number of people diagnosed with or dying from primary liver cancer per year could rise by more than 55% by 2040.

5 Oct 2022

Myocarditis may be attributable to monkeypox infection

A new study published in Emerging Infectious Diseases found that myocardial infiltration could cause myocarditis during monkeypox virus infection.

5 Oct 2022

Designing a new treatment to treat migraine effectively

In this interview, we speak to Mudra Kapoor, Vice President of Global Medical Affairs for Neuroscience at AbbVie, about atogepant, their new treatment option for migraine.

From AbbVie 26 Sep 2022

BU investigator wins highly competitive awards to study the role of proteases in regulation of cellular defenses

Mohsan Saeed, PhD, assistant professor of biochemistry at Boston University School of Medicine (BUSM), has received a five-year, $2 million R35 grant from the National Institute of General Medical Sciences, as well as a five-year, $2.5 million R01 grant from the National Institute of Allergy and Infectious Diseases.

20 Sep 2022

Monkeypox infection in a smallpox-vaccinated patient

In a recent study published in the Emerging Infectious Diseases journal, researchers at Madigan Army Medical Center assessed the characteristics of monkeypox infection in a patient vaccinated against smallpox.

20 Sep 2022

Pakistan faces widespread outbreaks of infectious diseases amid unprecedented floods

Amid unprecedented floods which have affected 33 million people and damaged nearly 900 health facilities, Pakistan faces the risk of widespread outbreaks of diseases, including diarrhoea, dengue, malaria, polio and COVID-19.

9 Sep 2022

NIH animal study combines Paxlovid with Lagevrio against SARS-CoV-2 Delta

In a recent study posted to the bioRxiv* preprint server, researchers at the U.S National Institutes of Health demonstrated the efficacy of molnupiravir and nirmatrelvir, two oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antivirals in the rhesus macaque model, the closest proxy to humans.

7 Sep 2022

The currently available evidence on viral-induced parkinsonism

A new review attempts to summarize all known about the relationship between viral illness and parkinsonian disorders to facilitate further research.

31 Aug 2022

The safety, tolerability, and pharmacokinetics of a muco-trapping monoclonal antibody delivered by inhalation

Researchers conducted a phase I clinical trial of IN-006, an inhaled monoclonal antibody treatment for COVID-19.

24 Aug 2022

Study finds link between high-density lipoprotein and COVID-19

A new study has highlighted the significance of high-density lipoprotein COVID-19 pathogenesis and outcome.

24 Aug 2022

Direct acting antiviral medications for hepatitis C may improve PTSD symptoms

More than six percent of Americans will develop posttraumatic stress disorder (PTSD) in their lifetime. This potentially chronic condition disrupts lives, and can lead to or exacerbate existing health issues such as depression, anxiety, eating disorders, and suicidal thoughts.

22 Aug 2022

Hepatitis C News and Research

Latest Hepatitis C News and Research

Inhalation therapeutics against COVID-19

RNA-dependent RNA polymerase inhibitors in COVID-19 therapy

The involvement of minor intron-containing gene-encoded proteins in viral infections

Global burden of liver cancer could rise by more than 55% by 2040, analysis reveals

Myocarditis may be attributable to monkeypox infection

Designing a new treatment to treat migraine effectively

BU investigator wins highly competitive awards to study the role of proteases in regulation of cellular defenses

Monkeypox infection in a smallpox-vaccinated patient

Pakistan faces widespread outbreaks of infectious diseases amid unprecedented floods

NIH animal study combines Paxlovid with Lagevrio against SARS-CoV-2 Delta

The currently available evidence on viral-induced parkinsonism

The safety, tolerability, and pharmacokinetics of a muco-trapping monoclonal antibody delivered by inhalation

Study finds link between high-density lipoprotein and COVID-19

Direct acting antiviral medications for hepatitis C may improve PTSD symptoms

Study highlights the urgent need for combinatorial drug therapies for SARS-CoV-2

New CDC Vital Signs report: Few people diagnosed with hepatitis C receive timely treatment

New CDC Vital Signs report: Less than a third of people diagnosed with hepatitis C get timely treatment

Inexpensive, self-driven microfluidic chip rapidly detects Hepatitis C virus in about 45 minutes

International travel restrictions were a key intervention for slowing COVID-19 spread, study shows

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Hepatitis C News and Research

Latest Hepatitis C News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in